Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had heart failure for at least 6 months, with symptoms that are stable (not in crisis), where the heart failure is caused by blocked arteries, inflammation, or a genetic heart condition
- People who are willing to sign a consent form agreeing to take part in the trial
- People who agree to undergo specific tests, including heart ultrasound, ultrasound scans of the neck and brain blood vessels, and memory and thinking assessments
Who may not be able to join:
- People who have another serious, irreversible illness at the same time, such as advanced cancer
- People who have already been diagnosed with dementia, including severe dementia (based on scores from standard memory tests)
- People who have a mental health condition that could affect memory or thinking
- People whose heart failure is currently in an unstable or acute crisis state
- People whose heart failure has a reversible cause, such as heart failure brought on by a very fast heart rhythm, pregnancy-related heart problems, poisoning or toxic exposure, recent severe heart inflammation, or a recent heart attack
- People who have a narrowing of the aortic valve in the heart (aortic stenosis)
- People who have had a stroke in the three months before joining
- People whose skull does not allow the brain blood vessel ultrasound to be performed properly (confirm with trial site)
- People whose heart ultrasound images are not clear enough to take proper measurements
- People with severe anaemia (very low red blood cell levels, specifically haemoglobin below 8 g/dl)
- People who have a problem with alcohol or substance misuse
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Piotr Musialek, MD, DPhil, John Paul II Hospital
Phone: +48126142287
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients with at least moderate (i.e. mild or moderate) cognitive dysfunction (MMSE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.